Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Easy Mark who wrote (294)	3/20/1998 4:40:00 PM
From: Manny Gugliuzza	Read Replies (2) \| Respond to of 1510

800$$ a pop are you sure. i do not think to many people will be treating their cats even if it does go recombinant. it sure seems like a lot for an injection or is it the whole treatment with visit? if they can get this 50% product will not really make that much difference. still better production would mean more treatments at less cost to the company. actually the hepatitis vaccine is 200 - 300$ human rabies vaccine is 60-70 cost! so this may not be out of line for what it can do and what people would pay for this effectiveness even if it was out of pocket per year. good luck and be ready Greed for another testing next week. and this could always be a non event event too . depends on what company and how they will approach the expansion of production and distribution of product into the market. a.r